| Summary of Shareholders Equity Warrants Outstanding (Details) - shares shares in Thousands | 9 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Sep. 30, 2021 | Dec. 31, 2020 | |||||||||
| Equity [Abstract] | ||||||||||
| Shares Outstanding, beginning | 1,328 | [1] | 5,397 | |||||||
| Shares Issued | ||||||||||
| Shares Exercised | (320) | [2] | (2,576) | |||||||
| Shares Tendered | ||||||||||
| Shares Expired | (20) | (1,493) | [1] | |||||||
| Shares Outstanding, ending | 988 | [3] | 1,328 | [1] | ||||||
| 
 | ||||||||||
| X | ||||||||||
| 
- Definition Share based compensation arrangement by share based payment award non option equity instruments tendered. No definition available. 
 | 
| X | ||||||||||
| 
- References No definition available. 
 | 
| X | ||||||||||
| 
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 | 
| X | ||||||||||
| 
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
 |